Seroquel on glucose metabolism
Study identifier:D1441C00125
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Seroquel on glucose metabolism
Medical condition
schizophrenia
Phase
Phase 4
Healthy volunteers
No
Study drug
Seroquel (quetiapine)
Sex
All
Actual Enrollment
572
Study type
Interventional
Age
18 Years - 65 Years
Date
Study Start Date: 01 Apr 2004
Primary Completion Date: -
Study Completion Date: 01 Oct 2005
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca CNS Medical Group
AstraZeneca
